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SUMMARY 
Homocitrullylamino adenosine inhibits the incorporation of Ii4Clamino acids into a 
hot acid-insoluble form in cell-free systems derived from Escherichia coli and rat liver. 
The concentration necessary for one-half maximal inhibition in the E. coli system is 
i.l. Io -4 M. Addition of the intact molecule is necessary for the maximum inhibition. 
The inhibition does not appear to involve the activation of the amino acids or their 
transfer to s-RNA, but rather exerts its effect, like puromycin, at the level involving 
the s-RNA ribosomal complex. 
INTRODUCTION 
We recently reported on the isolation and characterization of HCAA, a nucleoside 
obtained from mycelia of Cordyceps militaris 1. The structural similarity of this com- 
pound to puromycin is shown in Fig. I. Since puromycin has been shown to inhibit 
the incorporation of [14C]amino acids into protein in cell-free extracts of liver 2, 
bacteria s, thymus 4, ascites tumor 5, and reticulocytesS, 7, we decided to test HCAA to 
see if it might exert a similar effect. In the studies reported here we have found that 
HCAA, like puromycin, inhibits the incorporation of amino acids into protein in cell- 
free extracts of both Escherichia coli and rat liver. 
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Fig. z. Structure of homocitru]lyla~ino adenosine and puromycin. 
Abbreviation: HCAA, homocitru]ly]amino adenosine. 
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MATERIALS AND METHODS 
E. coli R2 was grown in shaking culture at 37 ° in a medium containing I 9'0 
glucose, I 9'0 yeast extract, and 0.25 M potassium phosphate buffer (pH 6.5). The 
cells were harvested early in the log phase of growth in a Sharples centrifuge at IO ° 
and the paste obtained was stored at --20 °. The various cell-free fractions used as 
either sources of enzyme, s-RNA, or ribosomes were obtained as follows: The cells 
were ground with 2.5 g alumina (Alcoa A3o5)/g of frozen cells, followed by extraction 
with 2-3 volumes of buffer containing o.oi M Tris hydrochloride (pH 7.8), o.oi M 
magnesium acetate, 0.006 M mercaptoethanol and 0.06 M potassium chloride (stan- 
dard buffer of MATTHAEI AND NIRENBERGS). The mixture was centrifuged at o ° for 
20 rain at 30 ooo × g, and this centrifugation repeated two more times, the final one 
being for 60 rain. The supernatant fluid (crude 30 S) was dialyzed against 60 volumes 
of the standard buffer (dialyzed 30 S) followed by centrifugation at lO5 ooo x g  for 
2 h. The supernatant fluid from this centrifugation (dialyzed IOO S) was carefully 
separated from the precipitate (ribosomes), which were resuspended in standard buf- 
fer. All fractions were stored at --20 ° . 
s-RNA was obtained by extraction of the dialyzed IOO S fraction at 24 ° with an 
equal volume of 88 9'0 phenol (Mallinckrodt, "Gilt Label"). The turbid solution was 
centrifuged at 12oo × g for 15 mill and the phenol layer was re-extracted with another 
volume of standard buffer minus the mercaptoethanol. The aequeous layers were 
combined and extracted with ether 3 times to remove phenol. Residual ether was 
removed by aeration with nitrogen. Solid potassium acetate was added with stirring 
to give a final concentration of 2 9'0, followed by 2.5 volumes of 95 % ethanol. The 
heavy white precipitate resulting from this treatment was collected by centrifugation, 
resuspended in water, and treated with deoxyribonuclease at 24 ° for 15 rain, which 
resulted in a noticeable lowering in the viscosity of the solution. The s-RNA was ex- 
haustively dialyzed against large volumes of water and dried by lyophilization. 
Deacylation of the s-RNA was achieved by incubation in 0. 5 M Tris hydrochloride 
(pH 8.8) for 45 rain at 35 ° according to the procedure of YON EHRENSTEIN AND LIP- 
~tANN x°. The deacylated s-RNA was dialyzed overnight against water and dried by 
lyophilization. 
Reacylation of the s-RNA with amino acids was carried out by incubating ioo 
nag s-RNA in a final volume of IO ml with I / ,mole each of 21 amino acids including 
[14C]leucine (containing 12 #C), 0. 4 ml (dialyzed ioo S), i mmole Tris hydrochloride 
(pH7.2), 5o#moles magnesium acetate, 3o#moles ATP, 2oo/~moles phosphoenol- 
pyruvate, and 0.4 mg pyruvate kinase for io rain at 37 ° according to the procedure of 
VON EHRENSTEIN AND LIPMANN 1°. The reaction was stopped by adding phenol and 
the s-RNA reisolated by the procedure of yon EHRENSTEIN AND LIPMANN 1°. The final 
lyophilized product had a specific activity of 30o0 counts/rain/rag s-RNA. 
In experiments in which HCAA was tested as an inhibitor of protein synthesis in 
rat-liver homogenates, the livers of 125 g rats were minced with scissors, and homo- 
genized in a Potter-Elvehjem homogenizer in 2.5 volumes of medium X o f  ZAMECNIK 
AND KELLER 9. The homogenate was centrifuged at 4000 × g for 20 rain and the super- 
natant  fluid (crude liver extract) was used in the studies to be reported below. 
GTP, sodium phosphoenolpyruvate, ATP, and creatine phosphate were purchas- 
ed from Sigma Chemical Co. Pyruvate kinase (Boehringer) was purchased from 
Calbiochem. DL [I-14C]Leucine (specific activity 8-12 mC/mmole)was also purchased 
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from Calbiochem. Uniformly labeled amino acids from Chlorella hydrolysate was a 
product of Volk. Homocitrullylamino adenosine was isolated from the mycelia of 
Cordyceps militaris 1. Puromycin was purchased from Nutritional Bioehemicals. Chlo- 
romycetin was obtained from Parke Davis Co. Protein was determined by  the method 
of ROBINSON AND HOGDEN u. Homocitrulline was synthesized according to the proce- 
dure of STEVENS AND ELLMAN 12. 3'-Amino 3'-deoxyadenosine was obtained as a 
product of alkaline methanolysis of HCAAL 
RESULTS 
Initial experiments showed HCAA inhibited protein synthesis, therefore the 
level necessary to produce one-half maximal  inhibition was determined and compared 
with that  for puromycin and chloromycetin. The incubation period for this experi- 
ment was io rain at which time the incorporation of label into protein was still pro- 
ceeding at a linear rate in the uninhibited system. The levels of inhibitor necessary 
for half-maximal inhibition as derived from the graph in Fig. 2 were I . I .  10 -4 M for 
HCAA, 1.8.10 -5 M for chloromycetin and 2.2. io -e M for puromycin. 
°° 1 
t 
LOG (CONCENTRATION x IO ?) 
Fig. 2. Inhibition of protein synthesis by different concentrations of puromycin, chloromycetin, and 
HCAA. The incubations were carried out essentially as described by MATTHAEI AND NIRENBERG 8. 
Each reaction vessel contained in a final volurae of I ral: ioo/*raoles Tris buffer (pH 7.8), io/*rao- 
les magnesium acetate, 6/*moles raercaptoethanol, 5 °/*raoles potassium chloride, I/*raole ATP, 
5/*moles phosphoenolpyruvate, o.o 3/*mole GTP, 2o/*g pyruvate kinase, o.25/*mole tryptophan,  
7 o ooo counts/rain 1*C-labeled Chlorella hydrolysate (specific activity o.I 7 raC/mg), and 3.4 rag 
protein (dialyzed 3 o S). The concentrations of inhibitors present are indicated above, l~eaction 
vessels were incubated for io rain at  35 °, and stopped by the addition of I ml io  ~o trichloroacetic 
acid. Vessels were placed in a 9 o° water bath for 15 rain. The precipitated protein, collected by cen- 
trifugation, was washed 4 times with 5 % trichloroacetic acid, 2 times with 95 % ethanol, and 
2 times with ether. The precipitates, still wet with ether, were dissolved in 2 ral concentrated for- 
mic acid, and o.5-ml aliquots plated and dried for counting on glass planchets. The incorporation 
of radioactivity into protein is corrected by subtracting the radioactivity incorporated in a con- 
trol tube in which trichloroacetic acid was added prior to the addition of enzyme. O-C), puroray- 
cin; x - x ,  chlororaycetin; 0 - 0 ,  HCAA. 
That  the inhibitory nature of HCAA was not due to its hydrolytic products is 
shown in Table I. I-Iomocitrulline and 3'-amino 3'-deoxyadenosine as well as the two 
substances together were tested at a concentration which for the added intact mole- 
cule gave approximately half-maximal inhibition. Although some inhibition was ob- 
tained with these compounds it is obvious from the data that  the addition of intact 
HCAA produced a better  inhibition than its hydrolytic products. 
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TABLE I 
I N H I B I T I O N  OF PROTEIN SYNTHESIS  IN CELL-FREE EXTRACTS OF E.  coli BY HCAA AND ITS HYDROLY- 
TIC PRODUCTS 
These experiments were performed as described in the legend of Fig. 2 with the following exceptions: 
Incubation time was 15 rain instead of io min. The concentrations of inhibitors added are indi- 
cated below. 
Additions Counts/rain/rag protein 
Complete 459 
Complete + homocitrulline (Io-4M) 4o8 
Complete + 3'-amino 3'-deoxyadenosine 
(Io -4 M) 418 
Complete + 3'-arnino 3'-deoxy- 
adenosine (io-4M) + homocitrulline (lO -4 M) 394 
Complete + HCAA (i o -~ M) 221 
The synthes is  of p ro te in  from the  amino  acids  m a y  be thought  of as t ak ing  place  
in two m a j o r  steps,  the  ac t iva t ion  and  t ransfer  of the  amino ac ids  to s -RNA,  and se- 
condly,  the  t ransfer  of the  ac t i va t ed  amino  acid from s - R N A  to the  r ibosomal  prote in ,  
w i th  subsequent  release from the  r ibosome.  In  cell-free prepara t ions ,  puromycin  
appea r s  to exer t  i t s  i nh ib i to ry  effect on this  second sequence of eventsS, 18,14. In  an 
effort  to de te rmine  whe ther  HCAA might  be inh ib i t ing  a t  a s imilar  p lace  the experi-  
men t s  enumera t ed  below were carr ied out.  
The first  expe r imen t  involved  compar ison  of the  r ad ioac t iv i ty  incorpora ted  into 
the  hot  and  cold t r ichloroacet ic  ac id-prec ip i tab le  prote in .  I f  the  inhibi t ion  occurs at  
a si te s imilar  to t ha t  repor ted  for pu romyc in  in cell-free systems,  then  one might  ex-  
pec t  t h a t  the  decrease in counts  observed in the  cold t r ichloroacet ic  ac id-prec ip i tab le  
f rac t ion  would  be accoun ted  for chiefly b y  the decrease in counts  in the  hot  t r ichloro-  
acet ic  ac id -p rec ip i t ab le  fract ion (which measures  to ta l  protein) .  Resul t s  of an exper i -  
m e n t  designed to prove  this  po in t  are given in Table  I I .  As m a y  be no ted  in th is  ex- 
pe r imen t  t he  decrease in r ad ioac t i v i t y  in the  cold t r ichloroacet ic  ac id-prec ip i tab le  
f ract ion in the  presence of the  inhib i tors  can be accounted  for chiefly b y  the  decrease 
in the  r ad ioac t i v i t y  in the  hot  t r ichloroacet ic  ac id-prec ip i tab le  fract ion which measu-  
res protein.  This  implies  t h a t  no inh ib i t ion  occurred in the  ac t iva t ion  and  t ransfer  of 
the  amino  acids  to s -RNA.  
Ano the r  approach  t aken  to prove  this  po in t  involved  a series of exper iments  in 
TABLE II 
INCORPORATION OF [14C]AMINO ACIDS INTO THE COLD AND HOT TRICHLOROACETIC ACID-PRECIPITABLE 
FRACTIONS OF /~o coli EXTRACTS IN T H E  PRESENCE OF HCAA OR PUROMYCIN 
These experiments were performed as described in the legend of Fig. 2 with the following excep- 
tions: 2.9 mg dialyzed 3 ° S protein was used as the enzyme source. Incubations were carried 
out for 15 rain. For the cold trichloroacetic acid-precipitable protein, washings were carried out 
as described in Fig. 2 except all washings and centrifugations were done at 4 °. The concen- 
tration of HCAA was 5" lO-4 M while that for puromycin was I .lO -4 M. The values given are in 
counts/rain/rag protein. 
Additions Cold trichloToacetic acid Hot trichlofoacaic acid 
Complete 1668 484 
Complete + HCAA 1504 125 
Complete + puromycin 1386 3o 
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which the precipitated protein was washed exhaustively and centrifuged in the cold, 
then heated for 15 rain at 9 o°, and the radioactivity liberated in the supernatant frac- 
tion counted in the presence and absence of HCAA or puromycin. The results of such 
an experiment are seen in Table III.  In experiments in which significant inhibition of 
label into protein was observed (Lower part of Table III), the incorporation of label 
into s-RNA was not appreciably altered. 
TABLE I I I  
I N C O R P O R A T I O N  OF [ t I C ] A M I N O  A C I D S  I N T O  s -RNA I N  T H E  P R E S E N C E  A N D  A B S E N C E  O F  HCAA OR 
P U R O M Y C I N  
These exper iments  were performed as described in the legend of Fig. 2 with the following excep- 
tions: Incuba t ions  were carried out  for 15 min. Superna tan t  fractions were obtained by  s topping 
the reaction wi th  cold trichloroacetic acid, washing and centrifuging the precipitated protein at  
4 °, then heat ing the precipitated washed protein  with trichloroaeetic acid at  9 °°  for 15 min. Ali- 
quo ts  of the supe rna t an t  fraction obtained by  this procedure were then plated directly for coun- 
t ing after  three successive t r ea tmen t s  wi th  ether  to remove the trichloroacetic acid. The ho t  
trichloroacetic acid-precipitable protein was then  washed and counted as described in Fig. 2. The 
concentrat ion of HCAA and puromycin  was I .  I O  - 4  M .  
A dditions Counts/rain/rag 
Superna tan t  fraction (s-RNA) lZNA" 
Complete 36oo 
Complete + HCAA 351 o 
Complete + p u r o m y c i n  373 ° 
H o t  trichloroacetic acid-precipitable protein Protein 
Complete 346 
Complete + HCAA 165 
( o m p i ~  t e  + p u r ~ m l }  t i n  2 5 
" t { N . \  ,v; l~ ,,~1 i l i l a l ( : d  b y  ; t b b ! l l i l ] ! l g  2 4 a{ ) s !~ r i l ; l n , . } '  l l l~{[s \ ve t , 2  ~,([tli~.;~i!-:~ i , !  ~ I!t;Z i , l  i<X \ 
The third experiment demonstrating that the inhibition by HCAA involved the 
s-RNA ribosomal system is shown in Table IV. Here, s-RNA charged with labeled 
leucine was used as the source of amino acids for protein synthesis thereby bypassing 
the systems responsible for the activation and transfer of the amino acids to s-RNA. 
To control the possibility that the s-RNA may be releasing free amino acids, and the 
inhibition observed was actually on the activating or transfer system to s-RNA, a 
TABLE IV 
I N H I B I T I O N  O F  A M I N O  A C I D  I N C O R P O R A T I O N  F R O M  s - R N A  I N T O  P R O T E I N  
These exper iments  were performed as described in the legend of Fig. 2 wi th  the following excep- 
t ions: i mg s -RNA charged with [14C]leucine, prepared as described in the text ,  was used instead 
of the 1¢C-labeled Chlorella hvdrolvsate  and t ryp tophan .  4 mg unwashed r ibosomes prepared as 
described in the text  were used instead of 3.4 mg dialyzed 3 ° 5 fraction. Incuba t ion  t ime was 15 
rain. In Expt .  2, o.o 5 / ,mole  each of 21 amino acids including leucine were added. The concen- 
t ra t ion of I ICA. \  present  in Expt .  3 was 5 ' IO 4 M. The concentrat ion of puromycin  present  in Expt .  
4 was  5" lO-4 M. 
Expt. Additions Total counts 
incorporated 
1 Complete 296 
2 C o m p l e t e + a m i n o  acids 240 
3 Complete + HCAA 92 
4 Complete + puromycin  12 
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vessel was used containing non-labeled leucine and the 21 other amino acids. If  a 
significant deacylation occurred during the incubation, then the specific activity or 
the total  counts incorporated into the protein should be greatly lowered. From the 
results of this experiment, it can be seen that  HCAA does inhibit the overall conver- 
sion from s-RNA to ribosomal protein, and the overall deacylation during the course 
of the experiment is not significant. 
Puromycin has been observed to have an inhibitory effect on protein synthesis in 
mammalian as well as bacterial systems. Chlorolnycetin, on the other hand, inhibits 
the bacterial but not the mammalian system. To see whether or not HCAA resembled 
puromycin in this regard several experiments were carried out with a crude rat-liver 
homogenate. The results of a typical experiment are shown in Table V. As noted in the 
bacterial system, the inhibitory effect of HCAA is not as pronounced as that  observed 
with puromycin at the same molar concentration. Although it is not indicated in this 
series of experiments, chloromycetin at a concentration of 2.10 .4 M did not inhibit 
in this system. Therefore HCAA appears in this respect to resemble puromycin. 
TABLE V 
INHIBITION OF PROTEIN SYNTHESIS IN CRUDE RAT-LIVER HOMOGENATES BY HCAA AND PUROMYCIN 
Incuba t ions  were carried out  in a final volume of r.o mh  The complete sys tem contained 0. 7 ml 
of a crude rat-liver homogenate  prepared as described in the text,  I /zmole  ATP, 7.3 mg creatine 
phosphate ,  and 0.04/tC [14C]leucine (specific act ivi ty  I2 mC/mmole) .  Inh ib i tor  addit ions were 
made as indicated below. Reaction vessels were incubated in an a tmosphere  of n i t rogen-carbon  
dioxide (95 : 5) for I h at  37 °. At  the end of this period of time, the reaction was s topped by the 
addit ion of an equal volume of io  °/o trichloroacetic acid. The vessels were then heated at  9 °0 for 
15 min. The subsequent  t r ea tmen t  of the precipitated protein was the same as t ha t  indicated in 
the legend of Fig. 2. A control  vessel was also run in which the addit ion of the acid preceeded tha t  
of the enzyme. All subsequent  t r ea tment  of the control was the same as tha t  for the experimental  
vessels. The values given below have been corrected by  subt rac t ing  the counts  obtained in the 
control vessel from the experimental  vessels. 
Additions Total counts 
incorporated 
Complete 166o 
C o m p l e t e + H C A A  (2. IO 3 M) 36o 
C o m p l e t e + H C A A  (5" lO-4 M) 88o 
C o m p l e t e + p u r o m y c i n  (5" lO-4 M) 64 
DISCUSSION 
The structural similarity of HCAA to puromycin is shown in Fig. I. Both molecules 
may  be thought of as being derivatives of 3'-amino 3'-deoxyadenosine but differing in 
two major  respects. Puromycin has a dimethyl substitution on the amino group of 
adenine while HCAA does not, and secondly, the amino acid substitutions are diffe- 
rent on the 3'-alnino position of the nucleoside. The results of this work have shown 
that  3'-amino 3'-deoxyadenosine is not an effective inhibitor of protein synthesis, 
while the work of RABINOVITZ AND FISHER 5 have demonstrated that  the dimethyl 
substi tuted 3'-amino 3'-deoxyadenosine also is not an effective inhibitor of protein 
synthesis. Therefore it appears that  a substitution on the free nucleoside is necessary 
for the maximal inhibitory effect. Substitution of homocitrulline on the 3'-amino group 
yields a compound that  is about one-fiftieth as effective as puromycin. The leucine 
analog of puromycin which contains leucine in place of 0-methyl  tyrosine has also 
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been shown to be a less effective inhibitor than puromycin 6. Therefore it would seem 
that the maximal inhibitory action might be due to the O-methyl tyrosine substitu- 
tion since the leucine and homocitrulline derivatives are much less effective and the 
free aminonucleoside and its dimethyl substituted product do not inhibit at all. 
The fact that HCAA does inhibit protein synthesis even though less effective 
than puromycin is still consistent with the view that compounds of this type may be 
acting as analogs of amino-acyl-s-RNA 2. 
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